サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1619579

糞便微生物叢移植（FMT）の世界市場レポート 2024年

Fecal Microbiota Transplantation (FMT) Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
糞便微生物叢移植（FMT）の世界市場レポート 2024年
出版日: 2024年12月20日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

糞便微生物叢移植（FMT）市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.0％で11億2,000万米ドルに成長します。予測期間中の成長は、クロストリジウム・ディフィシル感染症（CDI）の罹患率の上昇、炎症性腸疾患の有病率の増加、研究開発活動の活発化、高齢者の増加、医療インフラの拡大に起因すると考えられます。この時期の主要動向としては、ドナーのスクリーニングと検便準備のための標準化されたプロトコルの作成、マイクロバイオーム分析の進歩、検便処理技術の改善、革新的な送達方法、合成または標準化されたマイクロバイオータベースの製品の開発などが挙げられます。

胃腸疾患の罹患率の増加は、今後の糞便微生物叢移植（FMT）市場の拡大に拍車をかけると予想されます。胃腸（GI）障害には、食道、胃、小腸、大腸（結腸）、直腸、肛門を含む消化管に影響を及ぼすさまざまな疾患が含まれます。消化管障害の増加の要因としては、ストレスレベルの上昇、座りっぱなしの習慣、加工食品の摂取量の増加などが挙げられます。糞便微生物叢移植は、消化管障害患者の健康な腸内細菌を回復させるために、特に再発性のクロストリジウム・ディフィシル感染症の治療に利用されています。例えば、非営利団体であるCrohn's and Colitis Canadaの報告によると、カナダにおける炎症性腸疾患（IBD）の患者数は急速に増加しており、2023年の32万2,600人（人口の0.8％）から2035年には47万人（人口の1.1％）に増加すると予測されています。2023年には1万1,000人（約48分に1人）が新たに診断され、2035年には1万4,000人（約38分に1人）に増加すると予測されています。その結果、消化器疾患の有病率の増加が糞便微生物叢移植（FMT）市場の成長を促進する重要な要因となっています。

糞便微生物叢移植（FMT）市場の主要企業は、消化器疾患の治療効果を改善するために、微生物叢ベースの生きたバイオ治療などの革新的なソリューションの開発に注力しています。微生物叢による生きた生物治療は、様々な疾患の治療のために腸内微生物叢を回復または変化させる治療として生きた微生物を使用することを含みます。例えば、2022年11月、スイスに本社を置くバイオ医薬品会社Ferring Pharmaceuticalsは、米国食品医薬品局（FDA）からREBYOTA（糞便微生物叢、live-jslm）の承認を取得しました。この新規のクラス初となる微生物叢による生きたバイオ治療は、再発性CDIに対する抗生物質治療後の18歳以上の個人におけるクロストリジオイデス・ディフィシル感染症（CDI）の再発を予防するように設計されています。REBYOTAは、この年齢層におけるクロストリジオイデスディフィシル（C. difficile）感染症治療後の再発予防に特に適応があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の糞便微生物叢移植（FMT）市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の糞便微生物叢移植（FMT）市場の実績：規模と成長、2018～2023年
  • 世界の糞便微生物叢移植（FMT）市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の糞便微生物叢移植（FMT）市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • 発酵
  • 生
  • 凍結保存
  • 世界の糞便微生物叢移植（FMT）市場ドナータイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • 便由来
  • 糞便由来
  • 全マイクロバイオーム由来
  • 世界の糞便微生物叢移植（FMT）市場：適応症別、実績と予測、2018～2023年、2023～2028年、2033年
  • クロストリディオイデス・ディフィシル感染症
  • 炎症性腸疾患
  • メタボリックシンドローム
  • その他
  • 世界の糞便微生物叢移植（FMT）市場：投与経路別、実績と予測、2018～2023年、2023～2028年、2033年
  • 経口
  • 直腸
  • 経鼻胃管
  • コロンカプセル
  • 世界の糞便微生物叢移植（FMT）市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • 専門クリニック
  • その他

第7章 地域別・国別分析

  • 世界の糞便微生物叢移植（FMT）市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の糞便微生物叢移植（FMT）市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 糞便微生物叢移植（FMT）市場：競合情勢
  • 糞便微生物叢移植（FMT）市場：企業プロファイル
    • Ferring Pharmaceuticals
    • Johns Hopkins Medicine
    • Seres Therapeutics
    • Taconic Biosciences
    • Enterome

第31章 その他の大手企業と革新的企業

  • RebIoTix Inc
  • Finch Therapeutics Group Inc
  • Locus Biosciences
  • Yeda Research and Development Co. Ltd
  • MicrobIoTica Limited
  • CosmosID Inc
  • AOBiome
  • Synthetic Biologics Inc.
  • Osel Inc.
  • OpenBiome
  • Asia MicrobIoTa Bank
  • Taymount Clinic
  • MicroBiome Therapeutics LLC
  • MaaT Pharma SA
  • Kallyope

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r20585

Fecal microbiota transplantation (FMT) is a medical procedure where a healthy donor's fecal material is transplanted into a recipient's gastrointestinal tract to restore the balance of beneficial microorganisms in the gut. This procedure is typically used to treat conditions where the gut microbiota is disrupted, such as recurrent clostridium difficile infection (CDI) that does not respond to standard treatments.

The main types of fecal microbiota transplantation (FMT) are fermentation, fresh, and cryopreservation. Fermentation in Fecal Microbiota Transplantation (FMT) refers to the process by which gut bacteria break down complex carbohydrates and fibers in the gastrointestinal tract, producing short-chain fatty acids and other metabolites that promote gut health. Donor types include stool-derived, fecal-derived, and whole-microbiome derived, used to treat various conditions such as Clostridioides difficile infection, inflammatory bowel disease, metabolic syndrome, and others. It is administered through oral, rectal, nasogastric, and colon capsule routes. The end users include hospitals, specialty clinics, and others.

The fecal microbiota transplantation (FMT) market research report is one of a series of new reports from The Business Research Company that provides fecal microbiota transplantation (FMT) market statistics, including the fecal microbiota transplantation (FMT) industry's global market size, regional shares, competitors with a fecal microbiota transplantation (FMT) market share, detailed fecal microbiota transplantation (FMT) market segments, market trends and opportunities, and any further data you may need to thrive in the fecal microbiota transplantation (FMT) industry. This fecal microbiota transplantation (FMT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fecal microbiota transplantation (FMT) market size has grown strongly in recent years. It will grow from $0.80 billion in 2023 to $0.85 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to a rising awareness of the gut microbiome, expanding therapeutic applications, the growth of personalized medicine, adoption in gastroenterology practices, a higher number of clinical trials, and increased funding and investments.

The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth during the forecast period can be attributed to the rising incidence of Clostridium difficile infections (CDI), an increasing prevalence of inflammatory bowel diseases, heightened research and development activities, a growing geriatric population, and expanding healthcare infrastructure. Key trends during this period include the creation of standardized protocols for donor screening and stool preparation, advancements in microbiome analysis, improved stool processing technologies, innovative delivery methods, and the development of synthetic or standardized microbiota-based products.

The increasing incidence of gastrointestinal disorders is anticipated to fuel the expansion of the fecal microbiota transplantation (FMT) market in the future. Gastrointestinal (GI) disorders encompass a variety of conditions that impact the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine (colon), rectum, and anus. Factors contributing to the rise in GI disorders include heightened stress levels, sedentary habits, and a greater intake of processed foods. Fecal microbiota transplantation is utilized to restore healthy gut bacteria in patients with gastrointestinal disorders, particularly for the treatment of recurrent Clostridioides difficile infections. For example, Crohn's and Colitis Canada, a non-profit organization, reported that the number of individuals with inflammatory bowel disease (IBD) in Canada is rapidly increasing, projected to rise from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). In 2023, 11,000 new cases are expected to be diagnosed (approximately one every 48 minutes), with this number increasing to 14,000 by 2035 (approximately one every 38 minutes). Consequently, the growing prevalence of gastrointestinal disorders is a significant factor driving the growth of the fecal microbiota transplantation (FMT) market.

Leading companies in the fecal microbiota transplantation (FMT) market are concentrating on developing innovative solutions, such as microbiota-based live biotherapeutics, to improve treatment effectiveness for gastrointestinal disorders. Microbiota-based live biotherapeutics involve using live microorganisms as therapeutic agents to restore or alter the gut microbiome for treating various diseases. For example, in November 2022, Ferring Pharmaceuticals, a biopharmaceutical company based in Switzerland, received approval from the US Food and Drug Administration (FDA) for REBYOTA (fecal microbiota, live-jslm). This novel, first-in-class microbiota-based live biotherapeutic is designed to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals aged 18 and older, following antibiotic treatment for recurrent CDI. REBYOTA is specifically indicated for preventing the recurrence of Clostridioides difficile (C. difficile) infection in this age group after such treatment.

In October 2022, SYNLAB Group, a Germany-based provider of medical diagnostic services, formed a partnership with Microba to improve access to advanced microbiome analysis and enhance patient health management. The collaboration aims to expand the availability of the myBIOME test across Europe and Latin America, building on its success in Spain and Colombia. Microba, an Australia-based biotechnology company, specializes in fecal microbiota transplantation (FMT) research and application.

Major companies operating in the fecal microbiota transplantation (FMT) market are Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc, Finch Therapeutics Group Inc, Locus Biosciences, Yeda Research and Development Co. Ltd, Microbiotica Limited, CosmosID Inc, AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope

North America was the largest region in the fecal microbiota transplantation (FMT) market in 2023. The regions covered in the fecal microbiota transplantation (FMT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fecal microbiota transplantation (FMT) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fecal microbiota transplantation (FMT) market consists of revenues earned by entities by providing services such as donor screening and testing, microbiome assessment, stool collection, processing and preparation, endoscopic delivery, clinical monitoring, and symptom management. The market value includes the value of related goods sold by the service provider or included within the service offering. The fecal microbiota transplantation (FMT) market also includes sales of oral capsules, colonoscopy-based FMT, nasogastric or nasoduodenal tube and lyophilized (freeze-dried) stool. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fecal Microbiota Transplantation (FMT) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fecal microbiota transplantation (FMT) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fecal microbiota transplantation (FMT) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fecal microbiota transplantation (FMT) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Fermentation; Fresh; Cryopreservation
  • 2) By Donor Type: Stool-Derived; Fecal-Derived; Whole-Microbiome Derived
  • 3) By Indication: Clostridioides Difficile Infection; Inflammatory Bowel Disease; Metabolic Syndrome; Other Indications
  • 4) By Administration Route: Oral; Rectal; Nasogastric; Colon Capsule
  • 5) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Companies Mentioned: Ferring Pharmaceuticals; Johns Hopkins Medicine; Seres Therapeutics; Taconic Biosciences; Enterome
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fecal Microbiota Transplantation (FMT) Market Characteristics

3. Fecal Microbiota Transplantation (FMT) Market Trends And Strategies

4. Fecal Microbiota Transplantation (FMT) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Fecal Microbiota Transplantation (FMT) Market Size and Growth

  • 5.1. Global Fecal Microbiota Transplantation (FMT) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Fecal Microbiota Transplantation (FMT) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Fecal Microbiota Transplantation (FMT) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fecal Microbiota Transplantation (FMT) Market Segmentation

  • 6.1. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fermentation
  • Fresh
  • Cryopreservation
  • 6.2. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Stool-Derived
  • Fecal-Derived
  • Whole-Microbiome Derived
  • 6.3. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clostridioides Difficile Infection
  • Inflammatory Bowel Disease
  • Metabolic Syndrome
  • Other Indications
  • 6.4. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By Administration Route, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Rectal
  • Nasogastric
  • Colon Capsule
  • 6.5. Global Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users

7. Fecal Microbiota Transplantation (FMT) Market Regional And Country Analysis

  • 7.1. Global Fecal Microbiota Transplantation (FMT) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Fecal Microbiota Transplantation (FMT) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market

  • 8.1. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fecal Microbiota Transplantation (FMT) Market

  • 9.1. China Fecal Microbiota Transplantation (FMT) Market Overview
  • 9.2. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fecal Microbiota Transplantation (FMT) Market

  • 10.1. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fecal Microbiota Transplantation (FMT) Market

  • 11.1. Japan Fecal Microbiota Transplantation (FMT) Market Overview
  • 11.2. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fecal Microbiota Transplantation (FMT) Market

  • 12.1. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fecal Microbiota Transplantation (FMT) Market

  • 13.1. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fecal Microbiota Transplantation (FMT) Market

  • 14.1. South Korea Fecal Microbiota Transplantation (FMT) Market Overview
  • 14.2. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fecal Microbiota Transplantation (FMT) Market

  • 15.1. Western Europe Fecal Microbiota Transplantation (FMT) Market Overview
  • 15.2. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fecal Microbiota Transplantation (FMT) Market

  • 16.1. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fecal Microbiota Transplantation (FMT) Market

  • 17.1. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fecal Microbiota Transplantation (FMT) Market

  • 18.1. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fecal Microbiota Transplantation (FMT) Market

  • 19.1. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fecal Microbiota Transplantation (FMT) Market

  • 20.1. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fecal Microbiota Transplantation (FMT) Market

  • 21.1. Eastern Europe Fecal Microbiota Transplantation (FMT) Market Overview
  • 21.2. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fecal Microbiota Transplantation (FMT) Market

  • 22.1. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fecal Microbiota Transplantation (FMT) Market

  • 23.1. North America Fecal Microbiota Transplantation (FMT) Market Overview
  • 23.2. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fecal Microbiota Transplantation (FMT) Market

  • 24.1. USA Fecal Microbiota Transplantation (FMT) Market Overview
  • 24.2. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fecal Microbiota Transplantation (FMT) Market

  • 25.1. Canada Fecal Microbiota Transplantation (FMT) Market Overview
  • 25.2. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fecal Microbiota Transplantation (FMT) Market

  • 26.1. South America Fecal Microbiota Transplantation (FMT) Market Overview
  • 26.2. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fecal Microbiota Transplantation (FMT) Market

  • 27.1. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fecal Microbiota Transplantation (FMT) Market

  • 28.1. Middle East Fecal Microbiota Transplantation (FMT) Market Overview
  • 28.2. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fecal Microbiota Transplantation (FMT) Market

  • 29.1. Africa Fecal Microbiota Transplantation (FMT) Market Overview
  • 29.2. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By Donor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Fecal Microbiota Transplantation (FMT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fecal Microbiota Transplantation (FMT) Market Competitive Landscape And Company Profiles

  • 30.1. Fecal Microbiota Transplantation (FMT) Market Competitive Landscape
  • 30.2. Fecal Microbiota Transplantation (FMT) Market Company Profiles
    • 30.2.1. Ferring Pharmaceuticals
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johns Hopkins Medicine
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Seres Therapeutics
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Taconic Biosciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Enterome
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Fecal Microbiota Transplantation (FMT) Market Other Major And Innovative Companies

  • 31.1. Rebiotix Inc
  • 31.2. Finch Therapeutics Group Inc
  • 31.3. Locus Biosciences
  • 31.4. Yeda Research and Development Co. Ltd
  • 31.5. Microbiotica Limited
  • 31.6. CosmosID Inc
  • 31.7. AOBiome
  • 31.8. Synthetic Biologics Inc.
  • 31.9. Osel Inc.
  • 31.10. OpenBiome
  • 31.11. Asia Microbiota Bank
  • 31.12. Taymount Clinic
  • 31.13. MicroBiome Therapeutics LLC
  • 31.14. MaaT Pharma SA
  • 31.15. Kallyope

32. Global Fecal Microbiota Transplantation (FMT) Market Competitive Benchmarking

33. Global Fecal Microbiota Transplantation (FMT) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fecal Microbiota Transplantation (FMT) Market

35. Fecal Microbiota Transplantation (FMT) Market Future Outlook and Potential Analysis

  • 35.1 Fecal Microbiota Transplantation (FMT) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Fecal Microbiota Transplantation (FMT) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Fecal Microbiota Transplantation (FMT) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer